申请人:ONO Pharmaceutical Co., Ltd.
公开号:EP2592081A1
公开(公告)日:2013-05-15
An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect.
The present invention provides a compound represented by the general formula (I):
(wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.
本发明的目的是提供一种对ENPP2具有抑制活性的药物,该药物的靶点与现有药物的靶点不同,可作为一种药物用于现有药物疗效不佳的尿排泄障碍患者。
本发明提供一种由通式(I)代表的化合物:
(其中各组的定义如描述中所定义)的具有ENPP2抑制活性的化合物、其盐或其溶液或其原药,以及含有它们作为活性成分的用于预防或治疗尿排泄障碍和/或改善其症状的制剂。